Drug-eluting stents and noncardiac surgery.
نویسندگان
چکیده
Correspondence Casa Sollievo della Soefferenza; and Department of Medical and Pediatric Sciences (Drs Catalano and Trovato), University of Catania. Financial/nonfi nancial disclosures : The authors have reported to CHEST that no potential confl icts of interest exist with any companies/organizations whose products or services may be discussed in this article. Correspondence to: Michele Maggi, MD, Department of Emergency Medicine, IRCCS Ospedale Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy; e-mail: [email protected] © 2014 American College of Chest Physicians. Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details. DOI: 10.1378/chest.13-2792
منابع مشابه
Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study.
BACKGROUND Guidelines recommend that noncardiac surgery be delayed until 30 to 45 days after bare-metal stent implantation and 1 year after drug-eluting stent implantation. METHODS AND RESULTS We used linked registry data and population-based administrative health care databases to conduct a cohort study of 8116 patients (≥40 years of age) who underwent major elective noncardiac surgery in On...
متن کاملInterventional Cardiology Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion A Population-Based Study
Background—Guidelines recommend that noncardiac surgery be delayed until 30 to 45 days after bare-metal stent implantation and 1 year after drug-eluting stent implantation. Methods and Results—We used linked registry data and population-based administrative health care databases to conduct a cohort study of 8116 patients (Ն40 years of age) who underwent major elective noncardiac surgery in Onta...
متن کاملPrevious coronary stent implantation and cardiac events in patients undergoing noncardiac surgery.
BACKGROUND Noncardiac surgery performed after coronary stent implantation is associated with an increased risk of stent thrombosis, myocardial infarction, and death. The influence of stent type and period of risk still have to be defined. METHODS AND RESULTS We linked the Scottish Coronary Revascularisation Register with hospital admission data to undertake a Scotland-wide retrospective cohor...
متن کاملPerioperative management of patients with coronary stents.
Perioperative coronary stent thrombosis is a catastrophic complication that can occur in patients receiving both bare-metal and drug-eluting stents. Noncardiac surgery appears to increase the risk that recently-placed stents thrombose, especially when surgery is performed early after stenting, and particularly if dual antiplatelet therapy is discontinued. We reviewed the existing data about the...
متن کاملNoncardiac surgery in patients with coronary artery stents.
T HE MANAGEMENT OF PATIENTS WHO UNdergo coronary artery stent implantation and subsequently require noncardiac surgery is a real and challenging clinical problem. In 2008, more than 800 000 percutaneous coronary procedures were performed in the United States, with coronary stents implanted in over 96% of cases. Approximately 5% of patients undergo noncardiac surgery in the 12 months following c...
متن کاملBrief review: coronary drug-eluting stents and anesthesia.
PURPOSE Anesthesiologists managing patients with drug-eluting stents (DES) face the challenge of balancing the risks of bleeding vs perioperative stent thrombosis (ST). This article reviews DES and the influence of antiplatelet medications related to their use. A perioperative management algorithm is suggested. Novel P2Y12 antagonists currently under investigation, including cangrelor and prasu...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Chest
دوره 145 5 شماره
صفحات -
تاریخ انتشار 2014